Article ID Journal Published Year Pages File Type
9366912 Pathologie Biologie 2005 4 Pages PDF
Abstract
Thirty-seven patients operated from a Dukes B2-C colon cancer were randomised to receive as adjuvant infusional chemotherapy, nine 5 FU and folinic acid courses with or without carboplatin, as standard (de Gramont ; 2 days every 2 weeks) or chronomodulated administration (4 days every 2 weeks). The overall tolerance was judged excellent with less than 7% courses with dose-adaptations. The two carboplatin arms presented an enhanced haematological toxicity, while some more cutaneous toxicity was observed in the chronomodulated arm with the three drugs.
Related Topics
Health Sciences Medicine and Dentistry Pathology and Medical Technology
Authors
, , , , , , , , ,